Material and Methods Study design and study population The ALS registry Swabia has been described previously in detail 15,16,17
"Microdosing" is a non-clinical term used to describe staying at a dose lower than the standard starting point or refusing to escalate the dose as scheduled
Patients should contact their GP or prescribing clinician if they experience: Severe or persistent abdominal pain , particularly in the upper right quadrant or radiating to the back, which could indicate biliary complications such as bile duct stones or pancreatitis Persistent vomiting that prevents adequate fluid or medication intake, risking dehydration Signs of dehydration including dark urine, dizziness, reduced urination, or extreme thirst Jaundice (yellowing of skin or eyes), which may suggest bile duct obstruction Severe diarrhoea lasting more than 48 hours or accompanied by blood Unexplained fever with abdominal symptoms Pancreatitis is a rare but serious potential side effect of GLP-1 receptor agonists
The SUSTAIN trials encompassed global international studies (SUSTAIN 1 through 10), with three additional trials dedicated to China and Japan [7]
L-Carnitine Fiche de synthse Nom commun L-Carnitine, carnitine Nom(s) scientifique(s) 3-hydroxy-4-trimthylammonio-butanoate Proprit(s) associe(s) Amliore les performances | Facilite la rcupration physique | Favorise la perte de poids Qu'est-ce que la l-carnitine
:max_bytes(150000):strip_icc()/Health-GettyImages-2112991427-c2c4d692054b4ff6933f01fc6c5be06c.jpg)
